N/A N=30 Diagnostic

Evaluate Patients With Chronic Hepatitis by Three-dimensional Force-controlled Ultrasound Measurement

Fatty Liver

Bottom Line

View on ClinicalTrials.gov: NCT02784925 ↗

Enrolled (actual)

Serious AEs

100.0%

Results posted

Jun 2017

Primary outcome: Primary: Subcutaneous Fat in Steatosis Patients — 9.54; 10.48; 5.24; 4.09 cm^3

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Ultrasound (US) B mode image (Device)
Age: Adult, Older Adult · 20+ yrs
Sex: All
Sponsor: Taipei Medical University WanFang Hospital
Primary completion: Jul 2016

Outcome Measures

Outcome	Result	p-value
PRIMARY Subcutaneous Fat in Steatosis Patients	9.54; 10.48; 5.24; 4.09	—

Summary

Ultrasound (US) B mode image is an alternative method to measure tissue structure and has proven to be an accurate technique to measure subcutaneous fat thickness. However, pressing the transducer onto the skin with too much force will significantly reduce the subcutaneous adipose tissue thickness. In this study, a force controlled system combined with US transducer was used for 3D subcutaneous fat imaging and reconstruction.

Eligibility Criteria

Inclusion Criteria

Aged between 20-65 adults who are confirmed have fatty liver by echo

Exclusion Criteria

none

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02784925). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.